The Charies Drew University (CDU) UCLA Cancer Center Partnership (Partnership) proposes to develop a cancer research training and mentoring program. This program will be built upon the Partnership's experience in having run funded programs for several years at CDU and at UCLA-JCCC and is designed to build CDU's capacity in training students, fellows, and faculty in areas of cancer research that focus on cancer health disparities in minority and underserved populations. Mentoring and training in cancer research will expose undergraduates, medical students, graduate students, and faculty to careers and/or training in cancer research. The development of successful and competent cancer researchers will make a significant impact on CDU's ability to reduce and eliminate cancer health disparities and their impact on racial and ethnic minority and socio-economically disadvantaged populations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA143930-05
Application #
8543590
Study Section
Special Emphasis Panel (ZCA1-SRLB-D)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
5
Fiscal Year
2013
Total Cost
$46,069
Indirect Cost
$31,648
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Sarkissyan, Marianna; Wu, Yanyuan; Chen, Zujian et al. (2014) Vitamin D receptor FokI gene polymorphisms may be associated with colorectal cancer among African American and Hispanic participants. Cancer 120:1387-93
Li, Jihong; Vootukuri, Spandana; Shang, Yi et al. (2014) RUC-4: a novel ?IIb?3 antagonist for prehospital therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 34:2321-9
Mathews Griner, Lesley A; Guha, Rajarshi; Shinn, Paul et al. (2014) High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells. Proc Natl Acad Sci U S A 111:2349-54
Lin, Lehang; Gaut, Daria; Hu, Kaishun et al. (2014) Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474). Int J Oncol 44:557-62
Okamoto, Ryoko; Gery, Sigal; Kuwayama, Yoshio et al. (2014) Novel Gemini vitamin D3 analogs: large structure/function analysis and ability to induce antimicrobial peptide. Int J Cancer 134:207-17
Ceribelli, Michele; Kelly, Priscilla N; Shaffer, Arthur L et al. (2014) Blockade of oncogenic I?B kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors. Proc Natl Acad Sci U S A 111:11365-70
Maxwell, Annette E; Young, Sandra; Rabelo Vega, Roena et al. (2014) Training Mixtec promotores to assess health concerns in their community: a CBPR pilot study. J Immigr Minor Health 16:310-3
Gery, S; Koeffler, H P (2013) Role of the adaptor protein LNK in normal and malignant hematopoiesis. Oncogene 32:3111-8
Yin, D; Ogawa, S; Kawamata, N et al. (2013) miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Oncogene 32:1155-63
Elshimali, Yahya I; Khaddour, Husseina; Sarkissyan, Marianna et al. (2013) The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients. Int J Mol Sci 14:18925-58

Showing the most recent 10 out of 16 publications